178 related articles for article (PubMed ID: 32277233)
1. Suppression of the solar ultraviolet-induced skin carcinogenesis by TOPK inhibitor HI-TOPK-032.
Roh E; Han Y; Reddy K; Zykova TA; Lee MH; Yao K; Bai R; Curiel-Lewandrowski C; Dong Z
Oncogene; 2020 May; 39(21):4170-4182. PubMed ID: 32277233
[TBL] [Abstract][Full Text] [Related]
2. Targeting PRPK and TOPK for skin cancer prevention and therapy.
Roh E; Lee MH; Zykova TA; Zhu F; Nadas J; Kim HG; Bae KB; Li Y; Cho YY; Curiel-Lewandrowski C; Einspahr J; Dickinson SE; Bode AM; Dong Z
Oncogene; 2018 Oct; 37(42):5633-5647. PubMed ID: 29904102
[TBL] [Abstract][Full Text] [Related]
3. Paeonol suppresses solar ultraviolet-induced skin inflammation by targeting T-LAK cell-originated protein kinase.
Xue P; Wang Y; Zeng F; Xiu R; Chen J; Guo J; Yuan P; Liu L; Xiao J; Lu H; Wu D; Pan H; Lu M; Zhu F; Shi F; Duan Q
Oncotarget; 2017 Apr; 8(16):27093-27104. PubMed ID: 28404919
[TBL] [Abstract][Full Text] [Related]
4. ADA-07 Suppresses Solar Ultraviolet-Induced Skin Carcinogenesis by Directly Inhibiting TOPK.
Gao G; Zhang T; Wang Q; Reddy K; Chen H; Yao K; Wang K; Roh E; Zykova T; Ma W; Ryu J; Curiel-Lewandrowski C; Alberts D; Dickinson SE; Bode AM; Xing Y; Dong Z
Mol Cancer Ther; 2017 Sep; 16(9):1843-1854. PubMed ID: 28655782
[TBL] [Abstract][Full Text] [Related]
5. Gossypetin Inhibits Solar-UV Induced Cutaneous Basal Cell Carcinoma Through Direct Inhibiting PBK/TOPK Protein Kinase.
Wang L; Zhang Z; Ge R; Zhang J; Liu W; Mou K; Lv S; Mu X
Anticancer Agents Med Chem; 2019; 19(8):1029-1036. PubMed ID: 30827262
[TBL] [Abstract][Full Text] [Related]
6. Cefradine blocks solar-ultraviolet induced skin inflammation through direct inhibition of T-LAK cell-originated protein kinase.
Fan X; Duan Q; Ke C; Zhang G; Xiao J; Wu D; Zeng X; Chen J; Guo J; Zhou J; Shi F; Zhu F
Oncotarget; 2016 Apr; 7(17):24633-45. PubMed ID: 27016423
[TBL] [Abstract][Full Text] [Related]
7. Orobol, 3'-hydroxy-genistein, suppresses the development and regrowth of cutaneous SCC.
Roh E; Kim JE; Zhang T; Shin SH; Kim BG; Li J; Ma X; Lee KW; Dong Z
Biochem Pharmacol; 2023 Mar; 209():115415. PubMed ID: 36657604
[TBL] [Abstract][Full Text] [Related]
8. Novel TOPK inhibitor HI-TOPK-032 effectively suppresses colon cancer growth.
Kim DJ; Li Y; Reddy K; Lee MH; Kim MO; Cho YY; Lee SY; Kim JE; Bode AM; Dong Z
Cancer Res; 2012 Jun; 72(12):3060-8. PubMed ID: 22523035
[TBL] [Abstract][Full Text] [Related]
9. PBK/TOPK Inhibitor Suppresses the Progression of Prolactinomas.
Zhu K; Cheng X; Wang S; Zhang H; Zhang Y; Wang X; Chen Y; Wu J
Front Endocrinol (Lausanne); 2021; 12():706909. PubMed ID: 35126305
[TBL] [Abstract][Full Text] [Related]
10. Mitotic kinase PBK/TOPK as a therapeutic target for adult T‑cell leukemia/lymphoma.
Ishikawa C; Senba M; Mori N
Int J Oncol; 2018 Aug; 53(2):801-814. PubMed ID: 29901068
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive Physicochemical Characterization, In Vitro Membrane Permeation, and In Vitro Human Skin Cell Culture of a Novel TOPK Inhibitor, HI-TOPK-032.
Eedara BB; Manivannan B; Alabsi W; Sun B; Curiel-Lewandrowski C; Zhang T; Bode AM; Mansour HM
Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958502
[TBL] [Abstract][Full Text] [Related]
12. T-LAK cell-originated protein kinase (TOPK): an emerging target for cancer-specific therapeutics.
Herbert KJ; Ashton TM; Prevo R; Pirovano G; Higgins GS
Cell Death Dis; 2018 Oct; 9(11):1089. PubMed ID: 30356039
[TBL] [Abstract][Full Text] [Related]
13. The TOPK Inhibitor HI-TOPK-032 Enhances CAR T-cell Therapy of Hepatocellular Carcinoma by Upregulating Memory T Cells.
Zhang Q; Zheng F; Chen Y; Liang CL; Liu H; Qiu F; Liu Y; Huang H; Lu W; Dai Z
Cancer Immunol Res; 2024 May; 12(5):631-643. PubMed ID: 38407902
[TBL] [Abstract][Full Text] [Related]
14. Are FDA-Approved Sunscreen Components Effective in Preventing Solar UV-Induced Skin Cancer?
Bode AM; Roh E
Cells; 2020 Jul; 9(7):. PubMed ID: 32664608
[TBL] [Abstract][Full Text] [Related]
15. 3-Deoxysappanchalcone Inhibits Skin Cancer Proliferation by Regulating T-Lymphokine-Activated Killer Cell-Originated Protein Kinase
Fu X; Zhao R; Yoon G; Shim JH; Choi BY; Yin F; Xu B; Laster KV; Liu K; Dong Z; Lee MH
Front Cell Dev Biol; 2021; 9():638174. PubMed ID: 33842463
[TBL] [Abstract][Full Text] [Related]
16. T-LAK cell-originated protein kinase (TOPK) phosphorylation of MKP1 protein prevents solar ultraviolet light-induced inflammation through inhibition of the p38 protein signaling pathway.
Li S; Zhu F; Zykova T; Kim MO; Cho YY; Bode AM; Peng C; Ma W; Carper A; Langfald A; Dong Z
J Biol Chem; 2011 Aug; 286(34):29601-9. PubMed ID: 21715333
[TBL] [Abstract][Full Text] [Related]
17. TOPK Affects Autophagy of Skin Squamous Cell Carcinoma by Regulating NF-KB Pathway through HDAC1.
Li J; Zhang ZC; Yuan XS; Tang SS; Wang T; Liu HF; Cao Y
Dis Markers; 2022; 2022():3771711. PubMed ID: 35756488
[TBL] [Abstract][Full Text] [Related]
18. T-lymphokine-activated killer cell-originated protein kinase functions as a positive regulator of c-Jun-NH2-kinase 1 signaling and H-Ras-induced cell transformation.
Oh SM; Zhu F; Cho YY; Lee KW; Kang BS; Kim HG; Zykova T; Bode AM; Dong Z
Cancer Res; 2007 Jun; 67(11):5186-94. PubMed ID: 17545598
[TBL] [Abstract][Full Text] [Related]
19. Photocarcinogenesis study of glycolic acid and salicylic acid (CAS Nos. 79-14-1 and 69-72-7) in SKH-1 mice (simulated solar light and topical application study).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2007 Sep; (524):1-242. PubMed ID: 21921960
[TBL] [Abstract][Full Text] [Related]
20. TOPK promotes lung cancer resistance to EGFR tyrosine kinase inhibitors by phosphorylating and activating c-Jun.
Li Y; Yang Z; Li W; Xu S; Wang T; Wang T; Niu M; Zhang S; Jia L; Li S
Oncotarget; 2016 Feb; 7(6):6748-64. PubMed ID: 26745678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]